Earnings surprise are on cards for Collegium Pharmaceutical, Inc. (NASDAQ:COLL) ?

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) is reporting first quarter earnings results on Wednesday 9th May 2018, after the bell.

The consensus estimates from Thomson Reuters are loss of $ 0.49 per share from $ 59.75 million in revenue.

The same period from last year, COLL reportedly had loss of $ 0.79 per share on $ 2.17 million in revenue.

For the full year, analysts predict revenues of $ 301.83 million, while looking forward to loss of $ 0.58 per share.


About Collegium Pharmaceutical, Inc.

% Change
Market Cap
% Change from 52 Week Low
% Change from 52 Week High
Shares Outstanding
Dividend Rate

Be the first to comment

Leave a Reply